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Abstract
Integrating seasonal malaria chemoprevention (SMC), recommended by the WHO since
2012 to prevent malaria infection, with nutrition interventions may improve health outcomes
and operational efficiencies. This study assessed the effects of co-packaging interventions
on distribution coverage, nutrition, and clinical malaria outcomes in northern Nigeria. From
August to November 2014, community volunteers delivered sulfadoxine-pyrimethamine and
amodiaquine (SP-AQ) door-to-door each month to approximately 7,000 children aged 6–24
months in seven wards of Madobi, Kano State, Nigeria. In three of the wards children addi-
tionally received a lipid-based nutrient supplement (LNS–medium quantity), Plumpy Doz.
Coverage, adherence, and anthropometric outcomes were assessed through baseline, mid-
line, and endline household surveys. A facility-based case-control study was also conducted
to estimate impact on clinical malaria outcomes. Coverage of SP-AQ was similar between
arms at 89% (n = 2,409 child-months [88–90%]) in the SP-AQ only arm and 90% (n = 1,947
child-months [88–92%]) in the SP-AQ plus LNS arm (p = 0.52). Coverage of LNS was 83%
(n = 2,409 child-months [81–84%]). Whilst there were marked changes in anthropometric
status between baseline, midline and endline, these were largely accounted for by socioeco-
nomic status and must be interpreted with care due to possible measurement issues, espe-
cially length-based indices. Overall nutritional status of our most robust measure, weight-
for-age, does appear to have improved by endline, but was similar in the two study arms,
suggesting no additional benefit of the LNS. While the odds of clinical malaria among those
who received the intended intervention were lower in each study arm compared to children
who did not receive interventions (SP-AQ only OR = 0.23 [0.09–0.6]; SP-AQ plus LNS
OR = 0.22 [0.09–0.55]), LNS was not shown to have an additional impact. Coverage of SMC
was high regardless of integrating LNS delivery into the SMC campaign. Supplementation
with LNS did not appear to impact nutritional outcomes, but appeared to enhance the impact
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of SP-AQ on clinical odds of malaria. These results indicate that combining nutritional inter-
ventions with seasonal malaria chemoprevention in high-risk areas can be done success-
fully, warranting further exploration with other products or dosing.
Trial Registration: ISRCTN 11413895
Introduction
Malnutrition and malaria are priority challenges for global child health. Nutritional disorders
are implicated in over three million deaths in children under five annually (45% of total child
mortality) while malaria contributed to the deaths of 306,000 children in 2015 [1,2]. In Africa,
36% of children under five years old are stunted and 18% are underweight, while 16% of chil-
dren between two and ten years of age are infected with malaria parasites [1,2].
African children at risk for malaria are often also at risk for malnutrition. While the rela-
tionship between malnutrition and infectious disease is accepted to be generally synergistic,
the specific malnutrition-malaria interaction is not well-defined [3–5]. Risk of malaria in
stunted children may be increased by immune system inhibition [6,7], and several studies indi-
cate that malaria infection in underweight and wasted children amplifies case fatality by up to
ninefold [8–11]. At the same time, anemia and immune suppression resulting from malaria
infection contributes to or may be exacerbated by malnutrition [9,12–15]. Other studies show
conflicting results, with no association between infection and nutrition status or increased
incidence of malaria only in either underweight or stunted children [4,10,16–19].
Interventions targeting both acute malnutrition and infectious disease may therefore act
synergistically to improve overall child health. Previous research has shown that integrating
community interventions for multiple diseases increases coverage, improves health outcomes,
and is cost-effective [20–22]. In northern Nigeria, malnutrition and malaria are both highly
seasonal, spiking during the rainy season, lending them to an integrated approach. Malnutri-
tion rates are particularly high in the North West Zone, where Kano State is located: as of
Nigeria’s 2013 Demographic and Health Survey, 27% of under-five children in the North West
Zone and 40% of under-five children in Kano State suffered from severe acute malnutrition or
wasting [23]. In Kano, malaria prevalence among children under five was 60% in the 2015
Malaria Indicator Survey [24]. Combining resource-intensive community-directed interven-
tion campaigns for malnutrition and malaria may therefore provide a cost- and operationally
effective opportunity.
Seasonal malaria chemoprevention (SMC), in which children under five years are given a
monthly dose of anti-malarial drugs, is recommended since 2012 by the World Health Organi-
zation (WHO) in certain areas where malaria transmission is highly seasonal, such as the Sahel
sub-region of Africa [25]. SMC has been shown to reduce uncomplicated and severe malaria
episodes by 75% [26]. It is typically delivered door-to-door or through fixed or mobile health
service points and administered by community health workers. An estimated 6.4 million chil-
dren received SMC in 2016 [27].
SMC campaigns may provide an opportunity for delivery of an integrated package of child
health interventions. Medium-quantity lipid-based nutrient supplements (LNS-medium quan-
tity), such as Plumpy Doz, are used in food-insecure settings to provide additional calories,
protein, fats, and micronutrients to young children who are moderately malnourished and/or
at risk for severe acute malnutrition. While studies of the effect of LNS on anthropometric
indicators have found mixed results, provision of LNS to children at risk of undernutrition has
Health impact of preventative antimalarial and nutrition intervention
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improved weight gain, cognitive function, and hemoglobin concentration in some settings
[28–32]. Conveniently packaged as a ready-to-use food, LNS has been widely accepted by care-
takers and children [33–35]. Integrating LNS with SMC campaigns may thus offer an opportu-
nity to achieve additional improvements in child health beyond those achieved by distribution
of malaria chemoprevention alone. Therefore, in this study the aim was to determine whether
intervention coverage, child nutrition, and health outcomes are improved by packaging the
delivery of LNS through the SMC campaign compared with the delivery of SMC alone.
Methods
This study was designed as a pragmatic cluster controlled trial with a nested case-control.
Delivery of SMC combined with LNS was evaluated against delivery of SMC alone from
August 2014 to May 2015 in Madobi Local Government Area (LGA) of Kano State, Nigeria.
Madobi had an estimated population of 11,000 children under five years old in 2014, using
projected figures from the 2006 National Census [36]. The study was conducted in two non-
adjacent intervention arms consisting of seven wards (Yakun, Rikadawa, Kubaraci, Kafin
Agur, Burji, Kanwa, and Kauran Mata) (S1 Fig). The wards included in the study had similar
characteristics, including malaria endemicity (P. falciparum prevalence among 2–10 year olds
in 2014 was 30.4% in the SP-AQ only area and 28.4% in the SP-AQ plus LNS area) and season-
ality (the two intervention areas are separated by approximately 4 km) [37]. Density of health
facilities was similar (6 in each study arm), and a Community-based Management of Acute
Malnutrition (CMAM) facility was present in each study area. Both study areas are rural, and
most families in the study area are involved in agriculture, growing a variety of crops that
includes maize, rice, millet, groundnuts, potatoes, soybeans, and beans. Irrigation is not stan-
dard but is present.
Selection and description of participants
Children aged 6 to 24 months as of August 2014 living in the study wards were eligible to par-
ticipate in the trial. Children were excluded if: they had an allergy to any component of the
intervention; had taken SP or AQ within 30 days of intervention delivery; were HIV-positive
and taking co-trimoxazole; were unable to take oral medication; had suffered a severe acute ill-
ness including severe acute malnutrition (SAM), or had confirmed or suspected malaria at the
time of the household visit. Any child with severe acute illness or high fever was referred to the
nearest public health facility.
Children in the study population who sought care for fever in one of the 13 primary health
care facilities in the seven intervention wards between August 28 and November 30, 2014 were
also eligible for recruitment in the unmatched health facility-based case-control study. Chil-
dren not eligible for the intervention (SP-AQ or SP-AQ plus LNS) were excluded as well as
children referred to a CMAM facility in the past month or diagnosed with severe acute malnu-
trition (mid-upper arm circumference (MUAC) <11.5cm). A case was defined as any child
from the study population with a current or reported history of fever of�37.5 C within the
past 48 hours with a positive malaria rapid diagnostic test (mRDT). A control was defined as a
child from the study population with a current or reported history of fever of�37.5 C within
the past 48 hours and a negative mRDT test.
Interventions
The seven study wards were split into two groups based on geographic proximity. Children in
the northern wards of Kafin Agur, Burji, Kanwa, and Kauran Mata received SP-AQ only,
while children in the southern wards of Kubaraci, Rikadawa, and Yakun received SP-AQ and
Health impact of preventative antimalarial and nutrition intervention
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LNS. The group of wards, or arm, receiving the LNS intervention was randomly selected. Fol-
lowing community sensitization activities, a monthly SMC campaign of WHO pre-qualified,
co-blistered sulfadoxine-pyrimethamine plus amodiaquine (SP-AQ, brand name SPAQ-CO,
Guilin Pharmaceuticals) was delivered door-to-door in all seven wards by the Kano State Min-
istry of Health (KSMOH) network of Community-Directed Distributors (CDDs) for four con-
secutive months from August to November 2014. Timing of delivery coincided with the
typical malaria season and the period before November harvest when food is most scarce. Chil-
dren aged 6 months to 11 months received SP 262.5mg + AQ 75mg, while children aged 12 to
24 months received SP 525mg + AQ 150mg. All drugs were formulated as a three-day course
of tablets. All CDDs were trained in directly observed therapy (DOT) administration and
remained at households for 15 minutes following ingestion of the first dose of SP-AQ (and
LNS if applicable) to monitor for adverse reactions. Parents/guardians were given the remain-
der of the treatment courses with administration instructions.
In one of the two groups of wards, the southern group of Kubaraci, Rikadawa, and Yakun,
each monthly SP-AQ distribution was bundled with a one-month supply of the LNS product
Plumpy’Doz (Nutriset). Neither the deliverers of the intervention nor the outcome assessors
were blinded to the group allocations. For LNS, caregivers were instructed to feed children
aged 6–11 months the recommended dose of 23 grams per day, or 1.5 teaspoons three times
per day, while children 12–24 months received 46 grams per day, or three teaspoons three
times per day (in addition to breastmilk and other available foods) [38]. A daily dose of 46
grams of Plumpy’Doz contains 9.0mg of iron and is in accordance with WHO recommenda-
tions on iron supplementation in malaria-endemic areas [39,40].
Ethics statement
The Kano State Hospitals Management Board (KSHMB Reference #HMB/GEN/488/VOL. I)
approved all study protocols. Data collectors obtained written informed consent from a parent
or guardian aged 18 years or older for all study participants via signature, or fingerprint for
non-literate participants. The Kano State Hospitals Management Board approved the consent
procedure.
Evaluation
Coverage, adherence, and nutrition outcomes were measured using repeated cross-sectional
household surveys. Three household surveys were conducted: prior to the first round of distri-
bution in August 2014 among children aged 6–24 months (baseline), following the last round
of distribution in November 2014 among children aged 9–27 months (midline), and six
months after the last round of distribution among children 15–33 months old (endline)
(Fig 1). An electronic questionnaire was administered face-to-face in Hausa with the head of
household or caregivers using Open Data Kit version 1.4.4 (baseline and midline) and Sur-
veyCTO v1.31 (endline). Information was collected on demographics and household charac-
teristics, household food insecurity, recent illness/fever history, breastfeeding practices, and
receipt of and adherence to SP-AQ and LNS interventions. Anthropometric measurements
(length, weight, and MUAC) were also collected from children using UNICEF height boards
and infantometers (accurate to 0.1 cm), Seca scales (accurate to 0.05 kg) and MUAC tapes
(accurate to 0.1 cm). Enumerators performed each measurement twice, and if the difference
was greater than 10%, a third measurement was taken. The final measure was defined as the
mean of the two measurements, or the mean of the two closest measurements with the most
extreme measure excluded if a third measure was taken.
Health impact of preventative antimalarial and nutrition intervention
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For the case-control study, each of the 13 primary health care facilities in the study area par-
ticipated in a training based on national guidelines, covering mRDT performance and safety,
recruiting cases and controls, and completing study questionnaires. Facilities were supplied
with mRDTs during the study. Information on the cases and controls was collected from care-
givers by a healthcare worker using a register book, including: age and gender, history of dis-
ease including current and previous symptoms, mRDT results, recall of interventions received
in the last 30 days (SP-AQ only or SP-AQ plus LNS), and other malaria prevention measures
such as insecticide-treated net (ITN) use or indoor residual spraying (IRS) within the home.
Sample size calculations
Selection of households for surveys was done using a two-step design with enumeration areas
delineated for the 2006 National Census as the primary sampling unit, and households as the
Fig 1. Participant flow diagram of trial participants with three cross-sectional surveys and a nested case-control study.
https://doi.org/10.1371/journal.pone.0210692.g001
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secondary sampling unit. Using ward-level population estimates, a probability-proportional-
to-size calculation determined how many enumeration areas to include from each ward to
obtain a sample of 750 households from each intervention area (S1 Table). Simple random
sampling without replacement was done to select thirty enumeration areas per arm from a
total of 132 enumeration areas across the four wards in the SP-AQ only area and 103 enumera-
tion areas across the three wards in the SP-AQ plus LNS area. Within each selected enumera-
tion area, 25 households were selected using a listing of all eligible households within the
enumeration area. Household eligibility was defined as at least one child aged 6–24 months in
August 2014 within the household. All children aged 6 to 24 months in August 2014 in selected
eligible households were included in the survey. This sample is sufficient to demonstrate a 10%
absolute reduction in each outcome with 90% power at the 5% level of significance, assuming
50% prevalence at baseline and design effect of 1.5.
Sampling weights were calculated based on the MEASURE DHS approach for design and
sampling weights [41]. Weights were calculated as the inverse of the combined probability of
an enumeration area being selected from a ward and the probability of a household with at
least one child aged 6–24 months in August 2014 being selected from an enumeration area.
The case-control study aimed to include 604 controls and 302 cases, based on a ratio of 2
controls:1 case, assuming 60% intervention coverage, a detectable odds ratio of 0.6 of receiving
SP-AQ plus LNS compared with SP-AQ only, and an average of 6 confirmed malaria cases per
facility per month (two-tailed p<0.05, power = 0.8).
Data analysis
Primary outcomes were intervention coverage and adherence, nutritional status of children,
and clinical malaria incidence (Table 1). Analysis was conducted according to randomized
group allocation, regardless of whether the assigned intervention was received (i.e. intention-
to-treat). While all eligible children 3–59 months old in August 2014 received SMC as per pro-
grammatic recommendations, only children 6–24 months of age in August 2014 were included
in nutrition interventions and evaluation [40]; therefore, malaria outcomes were also restricted
to study participants ages 6–24 months at baseline. Because SP-AQ is considered effective for
four weeks after administration, each month of protection for each child is considered for cov-
erage calculations (four months per child per malaria season) [25]. Coverage was defined as
the proportion of child-months over which eligible children were protected out of all eligible
child-months, measured during the midline survey through a series of survey questions about
receipt and consumption of SP-AQ during each month of delivery. Adherence to SP-AQ was
Table 1. Summary of study outcomes, variable sources, and comparison populations.
Outcome Evaluation Comparison
Objective 1: Compare coverage and adherence to interventions
Percentage of children receiving intervention Household survey
(midline)
Intervention groups at end of
distribution
Intervention adherence Household survey
(midline)
Intervention at end of
distribution
Objective 2: Evaluate change in nutrition outcomes
Change in prevalence of stunting (LAZ), underweight
(WAZ), and wasting (WLZ and MUAC)
Household surveys Intervention groups and time
Change in mean z-scores (LAZ, WAZ, WLZ, MUAC) Household surveys Intervention groups and time
Objective 3: Evaluate change in malaria outcomes
Odds of clinical malaria Case-control Intervention groups
https://doi.org/10.1371/journal.pone.0210692.t001
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measured at the midline survey as the proportion of children who took the full three-day treat-
ment course in the final round of distribution. Adherence to LNS was measured as the propor-
tion of children who received LNS in the final round of distribution and consumed it in the 24
hours prior to the survey. Nutritional status was measured by the prevalence of stunting, wast-
ing, and underweight, and change in z-scores for length-for-age (LAZ), weight-for-length
(WLZ), weight-for-age (WAZ) and MUAC across survey rounds. Nutrition outcomes were
also compared between intervention arms at each time point.
Z-scores were generated using the WHO Anthro macro for Stata, which allows for compar-
ison of anthropometric measures with 2006 WHO Child Growth Standards [42]. Stunting was
defined as LAZ less than -2, wasting as WLZ less than -2 and underweight as WAZ scores of
less than -2. Low MUAC was defined as MUAC of less than 11.5 centimeters and severe acute
malnutrition (SAM) as WLZ scores of less than -3 and/or low MUAC. Extreme individual
LAZ (less than -6 or greater than 6), WAZ (less than -6 or greater than 5), WLZ (less than -5 or
greater than 5), and MUAC z-scores (less than -5 or greater than 5) were excluded; valid z-
scores for the same child were kept [42]. Although the standard definition of SAM also
requires assessment for oedema, this sign was not assessed and is therefore not part of the
SAM definition in this project. Household food insecurity covariates were created using the
standardized methodology from the Food and Nutrition Technical Assistance Project
(FANTA) question series [43]. A wealth index was constructed from household asset data
using principal components analysis [44,45]. Food insecurity was compared between interven-
tion arms and time points. Effects were expressed as weighted differences in z-scores and odds
ratios for stunting, wasting, and underweight.
Evidence for a difference in coverage and adherence between arms was assessed using a
Wald test. The test statistic was obtained by dividing the difference in coverage or adherence
by the cluster-adjusted standard error of the difference and comparing the resulting test statis-
tic to a standard normal distribution. The means and proportions were weighted to reflect the
sampling design and standard errors were adjusted for clustering within enumeration areas
using the Huber-White “sandwich” estimator of robust standard errors [46,47]. Differences in
nutrition outcomes and clinical malaria incidence were assessed using hierarchical multivari-
able regression models adjusting for clustering within enumeration area. Mean z-score and
malnutrition prevalence regression models included intervention arm, survey (time), and
interaction parameters for intervention arm and time as the measure of the potential addi-
tional effect of the intervention at midline and endline relative to baseline. All models were
adjusted for demographics, household food insecurity, and wealth.
A logistic regression model was used to compare the impact of intervention (SP-AQ or
SP-AQ plus LNS versus no intervention), study arm, and the interaction between intervention
and study arm on the odds of clinical confirmed malaria in cases versus controls, taking into
account clustering at the health facility. The model adjusted for demographics, month of
recruitment, illness in the two weeks prior to enrollment, and ITN use (S4 Table). Analysis
was restricted to children who received the intended intervention (SP-AQ in the SP-AQ only
arm; SP-AQ plus LNS in the SP-AQ plus LNS arm). All analyses were performed using Stata
13 (StataCorp) with significance defined as p<0.05.
Results
Approximately 7,000 children aged 6–24 months as of August 2014 (3,500 in each intervention
arm) were eligible to receive an intervention (Fig 1). Over the four months of intervention, 40
adverse reaction episodes to SP-AQ were reported across the seven study wards (38 vomiting/
spitting up, 2 fever).
Health impact of preventative antimalarial and nutrition intervention
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Cross-sectional survey results
There were 1,492 households at baseline, 1,220 households at midline, and 1,579 households at
endline with children 6–24 months old as of August 2014 (Fig 1). The midline survey inadver-
tently included households with children 3–63 months old; 77% of the 1,583 surveyed house-
holds met the eligibility requirement of at least one child 6–24 months old in August 2014 and
were included in the analysis.
A total of 4,968 children were sampled from the 4,291 households across both intervention
groups over the three surveys (Fig 1). Households in the two intervention arms were well bal-
anced with respect to household composition and size, as well as demographic characteristics
(education, religion, and ethnicity) and self-reported food security (Table 2, S2 Table). There
was a difference in household wealth observed in all three surveys with the SP-AQ only area
having significantly more households in higher wealth quintiles in all three survey rounds
(Chi-square p = 0.05 at baseline, p = 0.02 at midline, p = 0.06 at endline).
Coverage and adherence results (Table 1, Objective 1): Among children 6–24 months old in
August 2014, SP-AQ was received in 89.2% (n = 2,409 child-months; 95% CI 87.6–90.1%) of
all possible child-months across the four delivery rounds in the SP-AQ only area and 89.8%
(n = 1,947 child-months; 95% CI 87.7–91.8%) in the SP-AQ plus LNS area. There was no evi-
dence of a difference in coverage between arms (p = 0.52). Coverage of LNS, measured by the
proportion of potential child-months LNS received, was 82.5% (n = 2,409 child-months; 95%
CI 80.9–84.8%) in the SP-AQ plus LNS area, and both SP-AQ and LNS were received in 80.7%
(n = 2,409 child-months; 95% CI 78.6–82.8%) of child-months in this area. Coverage by num-
ber of treatments received is shown in Fig 2 and S3 Table.
Adherence to SP-AQ was measured at the midline survey as the proportion of children
who completed the 3-day treatment course among children who received SP-AQ in the last
distribution round. Reported adherence to the 3-day SP-AQ course was 83.8% (n = 369; 95%
CI 74–90.4%) in the SP-AQ only area and 77.5% (n = 708; 95% CI 68.6–84.4%) in the SP-AQ
plus LNS area (Wald test for difference in proportions between arms p-value = 0.27).
Adherence to LNS was also measured immediately following the final distribution round.
Among children 6–24 months old as of August 2014 who were visited by a CDD in the fourth
Table 2. Household survey sample sizes and demographic characteristics of respondents at baseline, midline, and endline.
Baseline Midline Endline
SP-AQ Only SP-AQ+LNS SP-AQ Only SP-AQ+LNS SP-AQ Only SP-AQ+LNS
Child age 6–24 months 9–27 months 15–33 months
Number of children 860 840 650 803 861 954
Number of households 751 741 656 564 775 804
Respondent is Head of Household
(proportion of households, 95% CI)
68.0% (56.9–79.1) 73.4% (65.6–81.4) 69.5% (62.3–76.7) 69.3% (61.9–76.7) 70.8% (64.4–77.2) 69.7% (62.2–77.2)
Respondent is Primary Caregiver (proportion
of households, 95% CI)
38.5% (26.8–50.1) 35% (25.8–44.2) 43% (32.1–53.8) 44.8% (37.1–52.4) 39.7% (29.6–49.8) 39.8% (32.1–47.5)
Wealth Index Quintiles (proportion of
households, 95% CI, adjusted to baseline)
Lowest 16.8% (8.5–25.2) 22% (13.4–30.6) 10.9% (6.2–15.7) 20.7% (12.9–28.5) 14.5% (8.8–20.2) 22.9% (15.8–29.8)
Lower 16.3% (10.8–21.8) 24.4% (20.0–28.9) 14.8% (10.7–18.8) 18.7% (13.9–23.5) 16.4% (10.1–22.6) 16.3% (12.2–20.4)
Middle 17.6% (13.6–21.6) 22.1% (17.5–26.6) 26.3% (21.8–30.7) 25.1% (20.5–30.0) 20.1% (15.3–24.9) 24.2% (19.4–29.0)
Higher 23.3% (18.0–28.5) 16.5% (12.3–20.7) 20.9% (17.4–24.4) 17.6% (12.0–23.1) 23.1% (17.8–28.4) 20.1% (14.1–26.0)
Highest 26% (17.1–34.9) 14.9% (8.6–21.3) 27.7% (21.0–34.3) 18.3% (12.3–24.2) 25.9% (16.6–35.3) 17% (11.1–22.9)
Household Self-Reported Food Secure 65.7% (54.0–75.7) 66.5% (59.5–72.8) 64.6% (55.9–72.5) 68.2% (59.1–76.1) 64.1% (54.4–72.8) 61.2% (52.0–69.5)
https://doi.org/10.1371/journal.pone.0210692.t002
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distribution round, 56.9% (n = 749; 95% CI 45.3–68.5%) reportedly consumed it in the 24
hours prior to the midline survey. Respondents of children who consumed LNS were also
asked how much was fed per dose. Among children 6–9 months of age during the interven-
tion, the median dose reported was 6 teaspoons (n = 53; range 1–20 teaspoons); among chil-
dren 10–24 months the median daily consumption was 7 teaspoons (n = 335; range 1–19
teaspoons). During the endline survey, respondents were asked to recall whether any doses of
LNS had been missed; reported complete treatment (no doses missed) was reported for 80.6%
(n = 111; 95% CI 69.3–91.1%) of children 6–9 months old during the intervention and 83.7%
(n = 532; 95% CI 75–92.5%) of children 10–24 months old during the intervention.
Nutrition outcome results (Table 1, Objective 2): Nutrition indicators were measured dur-
ing all three surveys. In accordance with WHO protocols for anthropometric data analysis,
18.5% of children at baseline, 19.4% of children at midline, and 0.5% of children at endline
were excluded from stunting outcomes due to extreme length-for-age z-scores. All of these
were due to biologically implausible low LAZ: range at baseline (-6.01 to -21.82), midline
(-6.02 to -16.17), and endline (-6.03 to -14.19). Underweight outcomes excluded 1.1% of the
baseline sample, 1.7% of the midline sample, and 0.1% of the endline sample with extreme
Fig 2. Distribution of the reported number of doses of SP-AQ and LNS received by intervention arm between August-November 2014, among
all surveyed children aged 6–24 months as of August 2014. Each column totals 100%. The SP-AQ only area encompassed 132 enumeration areas
while the SP-AQ plus LNS area included 103 enumeration areas.
https://doi.org/10.1371/journal.pone.0210692.g002
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weight-for-age z-scores. Extreme weight-for-length z-scores were excluded from wasting out-
comes (4.4% at baseline, 14% at midline, and 0.1% at endline), and extreme arm circumference
z-scores were excluded from MUAC outcomes (0% at baseline, 0.9% at midline, 0.2% at end-
line (Fig 1).
Baseline stunting prevalence (LAZ<-2) was 78.9% (n = 736; 95% CI 73–83.8) in the SP-AQ
only arm and 74.9% (n = 649, 95% CI 68.9–80.1%) in the SP-AQ plus LNS arm. Underweight
prevalence (WAZ<-2) was 55.1% (n = 856; 95% CI 49.8–60.2%) in the SP-AQ only arm and
51.5% (n = 826; 95% CI 43.5–59.5%) in the SP-AQ plus LNS arm at baseline, and wasting prev-
alence (WHZ<-2) was 15.1% (n = 785; 95% CI 11.9–18.9%) in the SP-AQ only arm and 13.8%
(n = 745; 95% CI 10.1–18.4) in the SP-AQ plus LNS arm at baseline. Low MUAC baseline
prevalence (<11.5 cm) was 3.8% (n = 860; 95% CI 2–7%) in the SP-AQ only arm and 5.7%
(n = 840; 95% CI 3.9–8.4%) in the SP-AQ plus LNS arm. At baseline, more than 1 in 10 chil-
dren in the study area had severe acute malnutrition as indicated by WHZ<-3 and/or low
MUAC: 10.1% (n = 860; 95% CI 7–14.4%) of children in the SP-AQ only arm and 11.6%
(n = 840; 95% CI 8.5–15.6%) of children in the SP-AQ plus LNS arm.
Between baseline and endline, prevalence of stunting, underweight, low MUAC, and severe
acute malnutrition were significantly lower within both intervention arms (p<0.01 for tests of
difference over time in all areas and indicators), while prevalence of wasting was similar in
both study arms at baseline and endline (S4 Table). Comparing intervention arms, there was
no evidence of differences in prevalence of nutrition outcomes at baseline (Table 3). There was
no evidence of differences in nutrition outcomes at midline or endline either, comparing chil-
dren who received four rounds of SP-AQ only with children who received four rounds of
SP-AQ in addition to four rounds of LNS (Fig 3). In accordance with changes in prevalence,
mean LAZ and WAZ z-scores were higher at endline compared to midline in both interven-
tion arms (Fig 4 and S4 Table).
Household wealth was the only variable included in the final model due to an imbalance
between arms at baseline. After adjustment for household wealth in multivariable regression
analysis of the intervention impact comparing the study arms over time, children in the
SP-AQ plus LNS area had significantly higher mean z-scores for MUAC than those in the
SP-AQ only area. No difference in mean z-scores was observed between intervention arms
with respect to any other nutritional anthropometric outcome (Table 3).
Table 3. Multivariable regression outcomes for impact of the nutrition intervention. Coefficients represent the difference in anthropometric indicators comparing
children 6–24 months as of August 2014 in each intervention arm across surveys (difference between arms in difference across time). Models are adjusted for household
wealth.
Midline-Baseline Comparison Endline-Baseline Comparison
Mean Z-Score (Continuous Outcome) Adjusted Difference in z-score 95% CI Adjusted Difference in z-score 95% CI p-value
Length-for-age z-score 0.16 -0.44–0.76 0.01 -0.39–0.42 0.83
Weight-for-length z-score -0.41 -1.01–0.20 -0.25 -0.71–0.21 0.38
Weight-for-age z-score -0.08 -0.57–0.42 -0.14 -0.53–0.26 0.78
MUAC z-score 0.26 -0.12–0.64 0.60 0.26–0.94 <0.01
Prevalence (Binary Outcome) Adjusted Odds Ratio 95% CI Adjusted Odds Ratio 95% CI p-value
Stunting (LAZ <-2) 0.94 0.45–1.97 1.18 0.70–1.98 0.67
Wasting (WLZ <-2) 1.35 0.69–2.62 1.69 0.90–3.18 0.26
Underweight (WAZ <-2) 0.97 0.52–1.80 1.43 0.87–2.33 0.25
Low MUAC (<115mm) 1.93 0.17–22.41 0.82 0.15–4.59 0.84
https://doi.org/10.1371/journal.pone.0210692.t003
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Case-control study results
In the case-control study, 380 children were recruited, of whom, 368 children were included in
the analysis (Table 1, Objective 3). In the SP-AQ arm, 156/179 recruited children received
SP-AQ (87.2%); 3 children also received LNS and were excluded from analysis. In the SP-AQ
plus LNS arm, 181/189 recruited children received SP-AQ plus LNS (95.8%); 9 children were
excluded from analysis as they only received SP-AQ. None of the recruited children received
only LNS. Of those tested for malaria in participating health facilities, 93 children (24.5%)
tested positive and 275 (72.4%) tested negative. The adjusted odds of clinical malaria among
children who reported taking SP-AQ within 30 days of consultation were 77% lower
(OR = 0.23; 95% CI 0.09–0.6; p = 0.003) than among those who did not receive any interven-
tion in the SP-AQ only area. The odds of clinical malaria among those who took SP-AQ plus
within 30 days of consultation were 78% lower than among those who did not receive any
intervention (OR = 0.22, 95% CI 0.09–0.55, p = 0.001). The interaction between site and inter-
vention arm was not significant (OR = 0.98, 95% CI 0.19–5.05, p = 0.986) (Table 4).
Discussion
The results of this study indicated nearly 90% coverage was achieved through door-to-door
delivery of the intervention. The high coverage attained during this intervention may be partly
Fig 3. Prevalence of malnutrition indicators by intervention arm and survey for children 6–24 months as of August 2014 who received four
doses of SP-AQ in the SP-AQ only arm or four doses of SP-AQ and four doses of LNS in the SP-AQ plus LNS arm.
https://doi.org/10.1371/journal.pone.0210692.g003
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credited to the local knowledge and experience of the CDDs in Kano State, who also work on
polio vaccination campaigns and other door-to-door delivery schemes for public health. This
result is important to public health intervention programming because coverage was high
despite the potential for decreased operational efficiency due to delivery of two interventions.
The LNS product used in this study was packaged in cartons of 36 325-gram cups (a one-week
supply per cup), requiring four cups delivered per eligible child each month [48]. Thus, each
11.7-kilogram carton covered nine children, making LNS a considerable additional weight to
carry for CDDs who may visit remote areas with no motorized transportation. Moreover,
approximately 80% of children who received SP-AQ reportedly completed the three-day
course across intervention arms. These results suggest that bundling interventions did not neg-
atively impact coverage or compliance in an SMC campaign with an existing cadre of CDDs.
This study also provides further evidence that SMC exposure is associated with reduced
clinical malaria episodes, an important result to consider as SMC is scaled up across the Sahel,
where reaching 23 million children considered at risk is a major operational challenge [27].
Apart from an improvement in MUAC z-scores, no impact was demonstrated on nutrition
outcomes with the addition of LNS to the SMC campaign. While an impact on stunting and
mean HAZ would not be expected due to the relatively brief timeframe of the intervention,
some improvements in weight gain and reductions in wasting were expected within the
SP-AQ plus LNS intervention arm. LNS may not have been consumed in the appropriate
Fig 4. Mean z-scores for anthropometric outcomes. Denominators vary by indicator due to outlier exclusions (see S4 Table). Midline and endline results are
limited to children who received four rounds of interventions.
https://doi.org/10.1371/journal.pone.0210692.g004
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doses to generate significant impact, or the type of supplement selected may not have delivered
sufficient nutrients for children at high risk for malnutrition, even when provided at the rec-
ommended dose. Other LNS evaluations have shown mixed results across intervention settings
[28–31,49]. It is also possible that the significant changes in nutritional indicators between
baseline and endline across intervention arms masked the impact of the LNS.
The differences in anthropometric indicators over time across both study arms were unan-
ticipated. The very high prevalence of stunting at baseline and midline and the apparent
marked improvement of both percent stunting and mean LAZ at endline was particularly
striking. Also striking was that baseline and midline WLZ were not correspondingly low as
would be expected in a very stunted, nutritionally compromised population. These observa-
tions may be explained by several factors, and it is likely that a mix of these reasons rather than
one alone is responsible. First, there may have been seasonal improvements in food availability
[50]–this is consistent with WAZ (and to a lesser extent mean MUAC) being better at endline
than at baseline or midline. Similarly, it is also possible that the SP-AQ intervention contrib-
uted to improvements in endline anthropometry by reducing the frequency and/or severity of
infections among participating children–this is also consistent with improvements in WAZ
between survey rounds. Next, measurement error may have played a part–this is particularly
Table 4. Characteristics and logistic regression results for malaria outcomes (positive mRDT) in recruited case-control study participants.
Controls [n = 275] Mean% (95%
CI)
Cases [n = 93] Mean% (95%
CI)
p-value Crude OR (95%
CI)
Adjusted OR (95%
CI)
p-value
Age (months) 15.7 16.9
6-11m (n = 93) 25.1 (20.3–30.6) 25.8 (17.8–35.7) 1 1
12-27m (n = 275) 74.9 (69.4–79.7) 74.2 (64.3–82.1) 0.891 0.96 (0.45–2.04) 1.35 (0.65–2.8) 0.42
Gender
Male (n = 190) 50.9 (45.0–56.8) 53.8 (43.5–63.7) 1 1
Female (n = 178) 49.1 (69.4–79.7) 46.2 (36.3–56.5) 0.63 0.89 (0.66–2.04) 0.96 (0.65–1.4) 0.82
Intervention received
None (n = 31) 4.7 (2.8–8.0) 19.4 (12.5–28.7) 1 1
SP-AQ or SP-AQ plus LNS
(n = 337)
95.3 (92.0–97.2) 80.6 (71.3–87.5) <0.001 0.21 (0.1–0.45) 0.23 (0.09–0.6) 0.003
Site
SP-AQ only (n = 179) 42.5 (36.8–48.5) 66.7 (56.4–75.5) 1 1
SP-AQ plus LNS (n = 189) 57.5 (51.5–63.2) 33.3 (24.5–43.6) <0.001 0.37 (0.11–1.24) 0.39 (0.15–0.96) 0.04
Interaction Intervention � Site 0.98 (0.19–5.05) 0.99
Presence of other symptoms
No (n = 207) 62.8 (56.7–68.4) 42.7 (32.8–53.2) 1 1
Yes (n = 151) 37.2 (31.6–43.1) 57.3 (46.8–67.2) 0.001 2.27 (0.94–5.45) 2.28 (0.8–6.54) 0.12
Bednet use in previous night
No (n = 207) 14.6 (10.8–19.3) 21.5 (14.3–31.1) 1 1
Yes (n = 308) 85.5 (80.7–89.2) 78.5 (68.9–85.7) 0.116 0.62 (0.25–1.58) 0.85 (0.33–2.17) 0.74
Indoor spraying in child’s
household
No (n = 364) 99.3 (97.1–99.8) 100
Yes (n = 2) 0.70 (0.18–2.90) 0 0.41 NA
Month of recruitment
August and September (n = 108) 29.5 (24.3–35.1) 29.0 (20.7–39.1) 1 1
October (n = 131) 34.2 (28.8–40.0) 39.8 (30.3–50.1) 1.18 (0.65–2.14) 1.41 (0.65–3.1) 0.39
November (n = 129) 36.3 (30.9–42.2) 31.2 (22.5–41.4) 0.56 0.87 (0.36–2.12) 1.9 (0.37–2.68) 0.99
https://doi.org/10.1371/journal.pone.0210692.t004
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true for length-based measures which account for the majority of our exclusions. Length is the
most technically difficult measurement to do; for instance, the legs of young infants may not
have been adequately extended at baseline and midline (legs are normally held in slight flexion,
the younger the infant the greater that being). This would have led to falsely low length mea-
surements and in turn falsely low LAZ and falsely high rates of stunting. This would also
explain the apparently ‘normal’ WLZ: flexed legs lead to falsely high WLZ. Measurement
errors could also have arisen due to our length boards having dual units (inches and centime-
ters) printed on the measurement tape. Finally, since we conducted repeat cross-sectional sur-
veys rather than cohort follow-up of the same children, it is possible that just by chance a
wealthier, healthier, better nourished cohort was selected at endline compared to baseline.
This would explain Table 3: taking socioeconomic status into account makes most cross-time
comparisons of anthropometry statistically non-significant. Regarding the impact of these
issues on validity of our remaining/overall anthropometric data: we consider our endline data
to be especially robust since there were very few exclusions at this time point; whilst different
numbers of exclusions at different time points might affect the validity of cross-time compari-
sons, inter-group comparisons would not be affected. Moreover, not all the anthropometric
measures were equally affected–any uncertainty about our length-based measures did not
affect weight-based measures (WAZ) and MUAC, hence those should be seen as reliable indi-
cators of changes in anthropometric status over time.
Frequent infections are known to contribute to poor nutritional status by increasing the
body’s nutritional demands, reducing appetite, and driving direct nutrient losses [5,9]. Similar
results have been observed with the use of trimethoprim-sulphamethoxazole (TS) prophylaxis
among HIV-exposed children in rural Uganda, which resulted in reductions in rates of stunt-
ing [4]. However, in the absence of a control group not provided with SP-AQ, no clear conclu-
sions on the impact of SP-AQ on nutritional outcomes can be made.
The odds of clinical malaria were lower in children who took SP-AQ compared to those
who did not in this study, providing further evidence that exposure to SMC has a protective
effect on clinical malaria incidence [26,27]. The addition of LNS did not modify the effect of
SP-AQ in this study. Even though the relationship between malaria and malnutrition is not yet
clear [19], an interaction remains biologically plausible as improvements in nutrition
strengthen the immune system and make the body more capable of fighting off infection
[28,32]. Larger, multi-center case-control studies are needed to confirm the observed findings
that adding LNS to SMC campaign reduced the odds of getting clinical malaria in this and
other settings.
Generalizability and limitations
This study may provide useful considerations for communities in the Sahel sub-region of
Africa where SMC campaigns are currently planned or ongoing. The cost-effectiveness of scal-
ing up such a program must also be considered; purchasing LNS may be a substantial barrier
as the cost of LNS per child, including shipping and taxes, is over 20 times the cost of SP-AQ
and bundling SP-AQ with LNS added 18% to the cost of an SP-AQ-only delivery campaign.
This study was subject to several limitations. First, the repeated cross-sectional study design
resulted in measurements taken from different children within the study population during
each survey round. This made it possible to assess changes in nutritional measurements only
at the population level. In addition, it was not possible to assess the potential impact of SP-AQ
on nutrition without a comparison group for the LNS intervention.
Second, possible measurement errors resulted in considerable loss of data available for
anthropometric analysis. Twenty-three percent of surveyed households at midline were
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excluded due to an error in the eligible age range of children during sampling, resulting in
uneven sample sizes between survey rounds. As discussed, a number of children were also
excluded from analysis due to extreme anthropometric z-scores (Fig 1); this could have been
due to errors in carrying out and recording anthropometric measurements, especially length-
based measures and especially during the baseline and midline surveys. Whilst this means that
cross-time comparisons should be made with great care, it does not invalidate inter-group
comparisons. The low percentage of exclusions at endline suggests that anthropometric data at
this final, most important time point are robust. Non-length based measures, which also
resulted in few exclusions, should also be seen as more robust and reliable than length-based
indices.
Third, recall bias may have been introduced in the surveys, especially around dosage for
Plumpy’Doz. The recommended dosage is 4.5 grams per day for children under one year of
age and nine grams per day for children 1–2 years of age; reported quantities consumed ranged
from 1–20 grams per day. This wide range of dosages may be reflective of problems with recall,
sharing the commodity with other members of the household, or misunderstanding dosage
instructions. Inconsistent dosing may have under- or over-estimated the overall effect of LNS
following the intervention.
Fourth, baseline food availability was reportedly high, and remained high throughout the
study, which may have limited our ability to detect an impact of adding LNS on health out-
comes. However, while two-thirds of households reported no food insecurity at baseline, more
than 70% of children measured at baseline were found to be stunted. This could indicate dis-
cordance between households’ perception of food security and actual nutrient intake by young
children, or could point to other contributing factors, such as frequent infection and/or poor
water, sanitation, and hygiene practices.
Finally, the nested case-control was subject to several limitations by design. Selection bias
may have been introduced since only public health facility patients were included; children
who sought treatment in the private sector, where nearly half of malaria treatment-seeking in
Nigeria is estimated to occur, would not have had the opportunity to participate [51]. In addi-
tion, only patients presenting with febrile illness were enrolled; children with parastaemia pre-
senting without fever could have been missed. Misclassification of positives and negatives was
possible as well. Controls were children seeking care for illness, and the range of severity of
these conditions or other, non-febrile health status, including malnutrition, is not known.
Lastly, the case-control study results were subject to the same limitations as the cross-sectional
surveys, including recall of exposure to SP-AQ and LNS and baseline food security.
Conclusions
This study investigated the operational and health impacts of combining nutrition and antima-
larial interventions. The sustained high coverage and adherence to an integrated intervention
strategy supports the efficiency of such bundled campaigns, and provides evidence that SMC
campaigns can be further improved beyond the current model. Whilst our anthropometric
outcomes (especially length-based measures and the over-time comparisons) should be inter-
preted with care due to possible measurement and other limitations discussed, results of the
case-control study indicated that the addition of nutrition interventions may be beneficial to
reduction of malaria. The best nutrition products in terms of cost efficiency and health out-
comes should be considered as candidates for distribution in malnourished areas across the
Sahel, including other types of LNS and other WHO-recommended supplementary foods such
as centrally-produced fortified blended foods or micronutrient powders. Alternatively, “nutri-
tion-sensitive” interventions such as vouchers or cash, as was recently tested with successful
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outcomes in Niger [52,53], could be considered. Altering dosage and timelines for implemen-
tation, and the addition of educational interventions for caregivers should also be considered.
More generally, this study provides new evidence for how delivery of community health
interventions may be improved. Given that addition of LNS, a bulky product, had no impact
on coverage achieved through SMC campaigns, programs could consider adding different
types of products to existing campaigns to enhance the efficiency of improving child health,
such as vaccines, essential medicines, education, and other health interventions.
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